Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksREDX.L Regulatory News (REDX)

  • There is currently no data for REDX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Price Monitoring Extension

25 Apr 2018 09:00

RNS Number : 0630M
Redx Pharma plc
25 April 2018
 

Price Monitoring Extension

The auction call period has been extended in this security by 5 minutes.

Auction call extensions give London Stock Exchange electronic order book users a further opportunity to review the prices and sizes of orders entered in an individual security's auction call before the execution occurs. A price monitoring extension is activated when the matching process would have otherwise resulted in an execution price that is a pre-determined percentage above or below the price of the most recent automated execution today.

The applicable percentage is set by reference to a security's Millennium Exchange sector. This is set out in the Sector Breakdown tab of the Parameters document at www.londonstockexchange.com/tradingservices

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
PMEUVRWRWRASURR
Date   Source Headline
27th Oct 20227:00 amRNSRedx to Present Poster at ASN Kidney Week
11th Oct 20227:00 amRNSFirst Patient Dosed in Phase 2a Trial for RXC007
3rd Oct 20227:00 amRNSRedx Presents RXC007 Preclinical and Phase 1 Data
29th Sep 20227:41 amRNSRedx to Present Poster on RXC007 at ICLAF
6th Sep 20227:00 amRNSTR-1: Notification of major holdings
31st Aug 20227:00 amRNSRedx to Present at the ERS International Congress
5th Aug 202211:52 amRNSCompletion of Placing and Director/PDMR Dealings
3rd Aug 20221:43 pmRNSProposed Secondary Placing of Shares via ABB
26th Jul 20221:47 pmRNSExercise of Options, PDMR Dealing and TVR
11th Jul 20227:00 amRNSRedx to Present at Virtual Investor Forum
27th Jun 20227:00 amRNSEncouraging Data on Porcupine and ROCK Inhibitors
23rd Jun 20227:00 amRNSInterim Results for the Six Months Ended 31 March
20th Jun 20227:00 amRNSRedx to Present at the ECM Congress
16th Jun 20227:00 amRNSNotice of Interim Results
15th Jun 20227:00 amRNSPan-RAF Inhibitor to Enter Clinical Development
9th Jun 20224:34 pmRNSTR-1: Notification of major holdings
8th Jun 20221:28 pmRNSTR-1: Notification of major holdings
7th Jun 20228:11 amRNSAdmission of Placing Shares
6th Jun 202211:56 amRNSResults of General Meeting
30th May 20227:00 amRNSRedx Presents Poster on RXC004 at ASCO
25th May 20227:00 amRNSRedx to Present at Jefferies Healthcare Conference
20th May 20227:00 amRNSNew Grant of Options
19th May 20222:34 pmRNSNew Grant of Options
19th May 202212:14 pmRNSResult of Accelerated Bookbuild
18th May 20226:28 pmRNSLaunch of Placing via Accelerated Bookbuild
27th Apr 20223:00 pmRNSRedx to Present at ASCO
8th Apr 20226:00 pmRNSRedx Presents Encouraging RXC004 Preclinical Data
5th Apr 20227:00 amRNSCollaboration with the Garvan Institute
30th Mar 20227:00 amRNSNomination of Clinical Development Candidate
24th Mar 20227:00 amRNSRedx to Present at the AACR Annual Meeting
10th Mar 20227:00 amRNSRedx Presents Encouraging Phase 1 Data for RXC007
9th Mar 20227:00 amRNSBoard Committee Changes
8th Mar 202212:30 pmRNSResult of AGM
2nd Mar 20227:00 amRNSRedx to Present at Cowen Health Care Conference
28th Feb 20227:00 amRNSRedx to Present at ILD Summit 2022
11th Feb 20224:43 pmRNSNotice of AGM
28th Jan 20227:00 amRNSNew Grant of Share Options
27th Jan 20227:01 amRNSAppointment of Non-Executive Director
27th Jan 20227:00 amRNSFinal Audited Results and Operational Update
25th Jan 202212:00 pmRNSNotice of Preliminary Results
23rd Dec 20217:00 amRNSRedx to Receive Milestone Payment of $9m from AZ
9th Dec 20214:41 pmRNSSecond Price Monitoring Extn
9th Dec 20214:36 pmRNSPrice Monitoring Extension
9th Dec 20212:06 pmRNSSecond Price Monitoring Extn
9th Dec 20212:00 pmRNSPrice Monitoring Extension
9th Dec 20217:00 amRNSRedx to receive milestone of $10m from Jazz
6th Dec 20217:00 amRNSRedx and Caris Life Sciences Announce Partnership
30th Nov 20217:00 amRNSRedx to Participate at Piper Sandler Conference
17th Nov 20217:00 amRNSRedx to Present at Jefferies London Conference
15th Nov 20217:00 amRNSFirst Patient Dosed in Phase 2 Trial of RXC004

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.